Ischaemic heart disease (IHD) is the commonest cause of death in diabetic foot ulcer patients and non-ulcerated diabetic patients, yet the mortality rate of diabetic foot ulcer patients is over twice that of non-ulcerated patients. As the cause of this increased mortality is not understood, we plotted the ratio of deaths due to ischaemic heart disease (IHD n ) to other causes of death (i.e. IHD n :OCD n ) against age for 242 diabetic foot ulcer patients and 121 controls (non-ulcerated diabetic patients). The IHD n :OCD n ratio rose above 1.0 from age 40 years onwards for diabetic foot ulcer patients, but from age 70 years onwards for controls, demonstrating differentially increased mortalities due to IHD. A population model involving summation of IHD n :OCD n ratios for neuropathic and neuroischaemic diabetic foot ulcer patients calculated an overall increased mortality rate of 1.8 compared with that of nonulcerated diabetics. The model predicted that a 25% reduction in neuropathic diabetic foot ulcer patients dying from IHD would eliminate the increased mortality, demonstrating that neuropathic rather than ischaemic ulceration defines the cause of increased mortality among diabetic foot ulcer patients.
Introduction
There is strong epidemiological evidence of excess mortality in association with the diabetic foot syndrome. Diabetic patients with leg and foot ulcers have a lower long-term survival (43%) than non-diabetic ulcerated individuals (56%) and general population controls (68%). 1 Reported mortality rates for diabetic foot ulcer patients range from approximately 10% with a median follow-up of 16 months 2 to 24% after 5 years. 3 Boyko and colleagues 4 reported a greater than two-fold increase in the mortality rate among diabetic foot ulcer patients compared with non-ulcerated diabetics, regardless of age, type and duration of diabetes.
Although clinical observations suggest that diabetic foot ulcer patients experience premature deaths compared with non-ulcerated subjects, a quantitative link between foot ulceration and increased mortality remains elusive. It is known that diabetic patients per se have a high risk of death due to cardiovascular disease, however, and this has been quantified in a multiple-risk factor intervention trial, which found that 53% of deaths in diabetic men were due to cardiovascular disease. 5 In addition, we have found that ischaemic heart disease (IHD) is the major cause of death in diabetic foot ulcer patients, accounting for 50.4% of certified causes. 6 As IHD could therefore account for half of diabetic foot ulcer patient deaths, comorbidities, such as foot ulceration, might produce increased or decreased mortality rates through modulation of the risk of death from IHD. The aim of this study was to investigate these relationships by modelling.
Patients and methods

PATIENTS
All diabetic foot ulcer patients studied attended the Diabetic Foot Clinic at King's Diabetes Centre, King's College Hospital, London, UK, and died between April 1989 and January 2000. Causes of deaths were established from death certificates obtained through the Family Record Centre in London. Diabetic foot ulcer patients included both patients with type 1 and those with type 2 diabetes, and were classified as having either neuropathic (absent ankle jerks and palpable foot pulses) or neuroischaemic ulcers (foot pulses not palpable).
The major immediate cause of death was classified as: cause 1a, 1b or 1c as stated on the death certificate. Death from IHD was classified as death due to a fatal myocardial infarction from occlusive coronary thrombosis or resultant fatal dysrhythmias. Details of post-mortem examinations were available for 41 patients.
The 'main cause of death' and the ratio of the number of deaths due to the main cause to those due to other causes, with respect to age at death, were determined.
The 121 controls were diabetes mellitus patients with no foot ulcers attending the diabetic clinic at King's College Hospital who died over a 10-year period from March 1990 to March 2000. They were stratified to match the diabetic foot ulcer group on age, sex and type of diabetes.
MODELLING
This was based on the assumption that mortality rates are a composite of rates of a number of different causes of death, and that an overall increase in the mortality rate (m) can be due to an increase in the incidence of one or more causes of death. Using the data of Boyko et al., 4 the increase in mortality rates for diabetic foot ulcer patients (m dfu ) can be expressed as: m dfu = 2.39 × m o where m o is an average rate for comparable non-ulcerated diabetic patients. If the nonulcerated diabetic population were used as controls, then m o = 1.0.
If a particular cause of death is significantly more prevalent than any 'other cause of death', however, then the population has a significantly higher risk of dying from this cause compared with any other cause of death, and any modulation of the mortality rate due to the main cause of death would exert the greatest effect on the normal mortality rate (m o ). Thus:
where m dfu is the mortality due to diabetic foot ulcer, m mcd is the mortality due to the main cause of death and m ocd is the mortality due to other causes of death.
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This model was further developed in conjunction with the results of the ratio of number of deaths due to the main cause of death to that from other causes, with respect to different age groups.
Results
Ischaemic heart disease was the major immediate cause of death (stated as cause 1a, 1b or 1c on the death certificate) for 45% (110) of diabetic foot ulcer patients and 45% (55) of controls, and was therefore the main cause of death. Fig. 1 shows the ratio of IHD n :OCD n (number of deaths due to IHD:number of deaths due to other causes) versus age at death for the 242 diabetic foot ulcer patients and 121 controls. The ratio demonstrated differentially increased mortality due to IHD, as the ratio rose above 1.0 in age groups 40 -49 through to 70 -79 years for diabetic foot ulcer patients, compared with age group 70 -79 years for controls. Figure 2 shows the causes of death determined by death certification of 112 diabetic foot ulcer patients, confirming that IHD was the main cause of death, occurring in 47% of cases compared with up to 13% for other causes (P = 0.029). More specifically, the post-mortem data in Table 1 show that, although 21.9% of IHD deaths occurred in patients with neuropathic foot ulcers, compared with 31.7% in those with neuroischaemic ulcers, 81.8% (nine) of patients with neuropathic ulcers died of IHD, compared with 43.3% (13) of those with neuroischaemic ulcers (P = 0.029). The overall proportion of patients with neuropathic ulceration was 26.8%.
To further investigate the role of IHD in the increased mortality rate associated with diabetic foot ulcer, a proportionate model of the diabetic foot ulcer population, based on the ratio IHD n :OCD n (see Notes on page 558), established a basis for the relationship between IHD and ulcer type, and the 2. Table 1 in the model, the calculated increased mortality rate in diabetic foot ulcer patients is 1.8 that of non-ulcerated diabetics.
The proportional effect of neuropathic ulceration on the diabetic foot ulcer population was calculated using the model, and is shown in Fig. 3 . Also shown is the effect of a hypothesized intervention that could reduce the risk of dying from IHD by 25%, i.e. from 0.82 (82%) to 0.62 (62%) in neuropathic diabetic foot ulcer; this dramatically reduces increased mortality such that no overall increase in mortality is seen if neuropathic ulceration occurs in up to 40% of the diabetic foot ulcer population. 
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Discussion
Studies showing increased mortality in diabetic foot ulcer patients have not identified the cause. The present study, however, identifies IHD as the major cause of death: neuropathic foot ulcer patients have almost twice the risk of dying compared with those with neuroischaemic foot ulcers. Both controls and diabetic foot ulcer patients had almost the same level of death due to IHD but, when the ratio of deaths due to IHD to other causes of death is examined, significant differences can be seen in the effect of IHD on mortality, both between diabetic foot ulcer patients and controls and within the diabetic foot ulcer population. Using the post-mortem data, a model based on these ratios gives an increased mortality rate of 1.8 times in diabetic foot ulcer patients due to IHD. Death certificates provide less accurate data, which is why we used only post-mortem cases in the model. This finding is also similar to that found for leg and foot ulcer patients in all medical specialties: a population study found an increased mortality rate of 2.0 that was attributable to IHD. 7 Boyko and colleagues 4 also observed that increased short-term mortality was primarily among neuropathic foot ulcer patients, although this conclusion was arrived at on a statistical basis, that would not allow the effect of risk reduction to be predicted. Controls are a problem because diabetic foot ulcers are associated with specific levels of neuropathy 8 and neither the general population nor nonulcerated diabetic patients per se provide a 'gold standard' to control for mortality rates specifically attributable to ulceration, as patients with similar levels of neuropathy are those who ulcerate. Observing two populations with different prevalences can compensate for the absence of a 'gold standard'. 9 By its proportionate nature, the model similarly addresses the control issue and is based on the differential death due to IHD between the two Reduced risk Increased IHD mortality in diabetic foot ulcer patients ulcer groups. The model assumes a defined equilibrium between IHD and other causes of death, which can be manipulated to take into account the variability often seen in the mortality of diabetic patients due to specific cardiac causes (see Notes). There are underlying complexities to observed differential IHD n :OCD n ratios and to the operation of the model, that are worthy of further examination. Nevertheless, the model facilitated the realization that neuropathic ulceration was the cause of increased mortality. Levels of neuropathy may therefore be potentially important in predicting mortality, for which neurotrophin receptor p75 may be a new and useful quantitative plasma marker. 10 As neuropathic ulceration was the main factor associated with increased mortality, we used the model to extrapolate data from postmortem patients to show the effect of decreasing the risk of early death from IHD of patients with neuropathic ulceration. Although a 25% decrease in the numbers of neuropathic diabetic foot ulcer patients dying earlier than nonulcerated diabetics would eliminate increased mortality, this may be difficult to achieve in practice. The approach we have taken therefore indicates the task necessary to bring the increased mortality of the diabetic foot ulcer population under control. Cardiovascular risk reduction measures, such as cholesterol-and blood pressure-lowering therapy, 11 need to be applied intensively to neuropathic patients with diabetes as preventative measures before ulceration. The link between neuropathic foot ulceration and the increased risk of death from IHD is not immediately apparent, however, although cardiac autonomic neuropathy correlates with advanced neuropathy in diabetes, 12 and foot ulceration is associated with significant levels of peripheral neuropathy. 13 There is also the possibility of other contributing factors, such as infection with Staphylococcus aureus, which may indirectly modulate mortality rates through mechanisms as yet unknown. 14 A more detailed study of the causes of death for diabetic foot ulcer patients would further our understanding of increased mortality in this highly vulnerable group.
Notes
As IHD is the major cause of death, mortality rates (m dfu ) are proportional to the ratio of m ihd :m ocd , and increase in mortality rates (∆ m ) can be derived from:
Assuming that at m o , mortality due to IHD n is in equilibrium with mortality due to OCD n , then: ∆ m = m dfu ÷ 1.0 IHD n where m dfu = _____ (ρ) OCD n and n is the number of patients dying who have different categories of diabetic foot ulcers. Where the equilibrium IHD n and OCD n alters, then an equilibrium factor (ρ) can be applied.
To determine ∆ m and understand the influence of ulcer type, altered mortality rates for diabetic foot ulcer patients are therefore expressed as:
∆ m ∝ ∆ n for neuropathic ulcers + ∆ n for ischaemic ulcers with ∆ n determined by IHD n :OCD n for the proportion of patients in each group.
